AC

Clinical Area · Hereditary Cancer

Inherited cancer risk, interpreted responsibly

Hereditary cancer testing identifies germline variants that increase the risk of developing cancer. Results carry implications not just for the patient but for biological relatives — making appropriate ordering, consent, and post-result support essential.

All hereditary cancer testing through AC is ordered and interpreted through a qualified physician. Positive findings are discussed with the ordering clinician before cascade testing or surgical decisions are made.

Multi-gene panel testing

A comprehensive 98-gene germline panel covers inherited predisposition across 23 cancer types, including BRCA1/2, Lynch syndrome genes, PALB2, ATM, CHEK2, and others.

Focused women's cancer panel

A targeted panel for hereditary breast, ovarian, and other women's cancer risk indications — appropriate when the clinical suspicion is more specific.

Cascade and family testing

Once a pathogenic variant is identified, single-site testing for biological relatives can be ordered to clarify individual risk before clinical decisions.

Clinical indications

When hereditary cancer testing is appropriate

Personal or family history of breast, ovarian, or colorectal cancer at young age

Multiple primary cancers in one individual or close relatives

Rare cancer types with known hereditary associations (e.g., male breast cancer)

Known pathogenic variant in the family — cascade testing for relatives

Treatment decisions where BRCA or other variant status is relevant (e.g., PARP inhibitor, olaparib)

Pre-surgical risk evaluation for contralateral mastectomy or risk-reducing surgery

Available tests

Hereditary cancer panels through AC

GC Genome

Hereditary Cancer Panel (98 genes)

A 98-gene germline panel covering inherited cancer predisposition across 23 cancer types.

Specimen: EDTA whole blood

TAT: 17–21 days

GC Genome

Hereditary Women's Cancer Panel

Focused hereditary cancer panel for breast, ovarian, and other women's cancer risk indications.

Specimen: EDTA whole blood

Hereditary cancer

Discuss a case or order a panel

Share the personal or family history, cancer type, and clinical question. AC can help identify the appropriate panel and guide the ordering process.

Suite 403, 133 Madina Munawara St, Amman, Jordan

+962 791 707 606 info@advancedconsensus.comMessage us on WhatsApp

For website inquiries, avoid patient names, national IDs, medical record numbers, or reports. Secure document exchange should happen through approved clinical channels.

Please do not include patient-identifiable information in this form.